ADILW - ADIAL PHARMACEUTICALS, INC.
0 0%
Share volume: 0
Last Updated:
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-04-2025 | 05-14-2025 | 08-13-2025 | 11-13-2025 | 03-05-2026 | |
| Assets | ||||||
| Total Assets | 5.044 M | 3.451 M | 6.802 M | 5.660 M | 6.673 M | |
| Current Assets | 4.059 M | 2.629 M | 6.079 M | 5.014 M | 6.181 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 3.751 M | 2.366 M | 5.915 M | 4.606 M | 5.881 M | |
| Total Non-current Assets | 981.830 K | 818.740 K | 720.010 K | 643.090 K | 489.700 K | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 985.178 K | 821.947 K | 723.076 K | 646.015 K | 492.484 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 5.044 M | 3.451 M | 6.802 M | 5.660 M | 6.673 M | |
| Total liabilities | 975.858 K | 1.324 M | 1.211 M | 1.155 M | 1.397 M | |
| Total current liabilities | 975.858 K | 1.324 M | 1.211 M | 1.155 M | 1.397 M | |
| Accounts Payable | 298.402 K | 565.765 K | 671.118 K | 556.284 K | 655.207 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.068 M | 2.127 M | 5.591 M | 4.505 M | 5.276 M | |
| Common stock | 86.063 M | 86.351 M | 91.773 M | 92.481 M | 95.249 M | |
| Retained earnings | -81.995 M | -84.224 M | -86.183 M | -87.976 M | -89.972 M |